Overcoming the Blood–Brain Barrier: Multifunctional Nanomaterial‐Based Strategies for Targeted Drug Delivery in Neurological Disorders
Small Science · 2024-12 · 4 (12)
DOI: 10.1002/smsc.202400232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Science, online erschienen am 06.10.2024. Verfasst von Callan D McLoughlin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Chemical Biology Rutgers, The State University of New Jersey 123 Bevier Road Piscataway NJ 08854 USA. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 244 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Science Foundation, New Jersey Commission on Spinal Cord Research.
Abstract (Originalsprache)
The development of effective therapies for neurological disorders is a growing area of research due to the increasing prevalence of these conditions. Some neurological disorders that are prevalent and remain difficult to treat are glioma, neurodegenerative disease, ischemic stroke, and traumatic brain injury. Subsequently, the therapeutic efficacy of small molecules, proteins, and oligonucleotides remains a challenge due to the presence of the blood–brain barrier (BBB), a highly selective semipermeable membrane. To this end, multifunctional nanomaterials have emerged as promising vehicles for targeted drug delivery to the brain, due to their ability to transport therapeutics across the BBB selectively. The design of advanced nanomaterial‐based drug delivery systems capable of overcoming the BBB is influenced by many factors, such as fabrication technique and surface modification. This review explores the diverse range of nanomaterials, including polymer, lipid, gold, magnetic, and carbon‐based nanostructures, capable of effectively passing the BBB. These materials cross the BBB via a variety of established transport mechanisms for targeted delivery of therapeutics to the brain. Moreover, the structure and function of the BBB are highlighted and the potential for nanotechnology to aid the treatment of neurological disorders based on their ability to undergo transcytosis into the brain is highlighted.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry and Chemical Biology Rutgers, The State University of New Jersey 123 Bevier Road Piscataway NJ 08854 USA.
- Department of Regulatory Science Graduate School Kyung Hee University Seoul 02447 Republic of Korea.
- Institute of Regulatory Innovation through Science (IRIS) Kyung Hee University Seoul 02447 Republic of Korea.
ORCID-Profile: Ki-Bum Lee
Förderung
- NIGMS NIH HHS
- National Science Foundation
- New Jersey Commission on Spinal Cord Research
- Foundation for the National Institutes of Health
- Alzheimer's Association
- Congressionally Directed Medical Research Programs
- National Heart, Lung, and Blood Institute
Zitieren
APA
McLoughlin, C. D., Nevins, S., Stein, J. B., Khakbiz, M., & Lee, K. B. (2024). Overcoming the Blood–Brain Barrier: Multifunctional Nanomaterial‐Based Strategies for Targeted Drug Delivery in Neurological Disorders. Small Science, 4(12). https://doi.org/10.1002/smsc.202400232
Vancouver
McLoughlin CD, Nevins S, Stein JB, Khakbiz M, Lee KB. Overcoming the Blood–Brain Barrier: Multifunctional Nanomaterial‐Based Strategies for Targeted Drug Delivery in Neurological Disorders. Small Science. 2024;4(12). doi:10.1002/smsc.202400232
BibTeX
@article{McLoughlin2024,
author = {McLoughlin, Callan D and Nevins, Sarah and Stein, Joshua B and Khakbiz, Mehrdad and Lee, Ki-Bum},
title = {Overcoming the Blood–Brain Barrier: Multifunctional Nanomaterial‐Based Strategies for Targeted Drug Delivery in Neurological Disorders},
journal = {Small Science},
year = {2024},
volume = {4},
number = {12},
doi = {10.1002/smsc.202400232}
}
EUVIMED